Skip to main content

Market Overview

Ekso Bionics Raises $40M From Upsized Equity Offering At 28% Discount, Shares Tank

  • Ekso Bionics Holdings Inc (NASDAQ: EKSO) has increased the size of the previously announced public offering to 3.9 million common shares at $10.25 per share, raising around $40 million in gross proceeds from the previous offer of 975,610 shares for $10 million. The offer price is at a 28% discount on the last close price of $13.07 on Monday.
  • Underwriters have an option to purchase additional 585,366 shares of common stock.
  • The offering is expected to close by February 11.
  • H.C. Wainwright & Co. is acting as the sole book-running manager for the offering.
  • Ekso Bionics will use the net proceeds for working capital and other general corporate purposes, debt repayment, and acquisitions.
  • According to interim fourth-quarter results, revenue is estimated at $2.3 million, down from $3.7 million a year ago. FY2020 is expected to be approximately $8.9 million, lower than $13.9 million in 2019. The cash balance on December 31 stood at $12.9 million.
  • Price Action: EKSO slipped 20.8% at 10.35 in premarket trading on the last check Tuesday.

Related Articles (EKSO)

View Comments and Join the Discussion!

Posted-In: Earnings News Guidance Health Care Offerings General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at